Immediate Impact
1 by Nobel laureates 62 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
Works of Yanxia Li being referenced
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yanxia Li | 167 | 11 | 207 | 153 | 10 | 398 | |
| Ewa Cendrowicz | 167 | 33 | 166 | 229 | 10 | 453 | |
| Xiangyi Shi | 160 | 18 | 70 | 153 | 13 | 392 | |
| J Lombardero | 234 | 11 | 159 | 117 | 9 | 436 | |
| G. Pusztaszeri | 189 | 38 | 124 | 59 | 13 | 395 | |
| Eric Gobin | 184 | 14 | 141 | 47 | 13 | 399 | |
| Camino Bermejo‐Rodríguez | 218 | 10 | 113 | 30 | 15 | 354 | |
| Alexandra Gonzalez | 209 | 33 | 110 | 53 | 10 | 382 | |
| Sun Joo Lee | 248 | 17 | 101 | 46 | 13 | 423 | |
| Mathieu Darsigny | 217 | 15 | 98 | 67 | 10 | 385 | |
| Mi‐Young Kim | 257 | 20 | 93 | 61 | 15 | 390 |
All Works
Loading papers...